在当今不断发展与变化的全球经济中，战略伙伴关系是释放增长机遇的关键。以迪拜为中心枢纽，中国 企业与中东地区正在开启合作新篇章。作为东西方之间的重要桥梁，迪拜已成为中国企业寻求全球扩张 的首选目的地。 迪拜与中国是天然的合作伙伴。双方在经济上的互补优势，为市场的共同增长打开了机遇之门。中国的 经济规模和全球雄心，与迪拜作为贸易、投资及创新领域的前沿枢纽的定位高度契合。这一伙伴关系不 仅建立在商业基础之上，更植根于共同的目标和长期愿景。 多个数据亦在佐证这一上升趋势。中国连续多年成为迪拜的最大贸易伙伴。2024年，双方的非石油贸易 超过800亿美元，年增长率达19%。2015年至2023年之间，中国在迪拜的投资总额达到54亿美元。截至 2025年上半年，已有6000多家中国企业注册为迪拜商会的活跃会员。这些数字反映出迪拜已成为备受中 国商界信赖的全球增长平台。 迪拜的战略位置连接亚洲、非洲和欧洲，是共建"一带一路"倡议的重要门户。同时，迪拜先进的基础设 施、全球一流的物流设施，以及聚焦行业发展的多个自贸区，为中国企业提供了无缝进入全球市场的机 遇。 在迪拜经济议程(D33)的指引下，迪拜旨在到2033年实现经济翻 ...

上述公告引发了资本市场的关注，医疗资产也能"代币化"，华检医疗显然开创稳定币交易所先河。对于公司的"跨界"创举，市场也不乏质疑的声 音，认为公司"会讲故事"、涉嫌蹭"稳定币"的风口。 7月21日，港股的华检医疗（01931.HK）跳空高开并急速上涨，一度涨58%(4.66港元），创下上市以来的新高。随后公司股价震荡回落，收盘仍 大涨32.88%，报3.92港元/股，市值63.56亿港元。 值得注意的是，华检医疗上周五亦录得大涨超20%，两日内累计上涨60%，公司成交量也随之放大，近两个交易日累计成交逾5000万港元，投资 者疯狂涌入，公司沉寂许久的股价一下子成了香饽饽。 股价暴涨的导火索源于近期的重磅利好—— 消息面，7月17日，华检医疗发布公告称，公司已正式启动向香港、以及美国相关监管部门提交稳定币发行牌照申请的部署工作，准备冲刺全球首 个在港美两大市场获得稳定币发行资质的医疗科技企业。 7月20日，公司再次发布公告称，旗下美国全资子公司IVDGROUPINC.已完成注册，即日起公司透过该子公司正式启动向美国监管机构提交稳定 币牌照申请的程序；同时以医疗创新药NewCo资产为核心的Web3交易所生态——IV ...

Summary of Key Points Core Viewpoint - The Hong Kong Stock Exchange (HKEX) saw 11 companies submit applications for listing from June 30 to July 6, with no companies passing the listing hearing during this period. Additionally, 7 companies initiated their public offerings, and 5 new stocks were listed. Group 1: Companies Submitting Applications - Puxiang Health Holdings Limited is a leading provider of integrated medical and elderly care services in North China, ranking second in revenue among its peers and first in revenue growth from 2022 to 2024 [2] - Magnesium Health Technology Co., Ltd. focuses on innovative payment solutions for medical expenses, being the largest provider of innovative health insurance solutions in China by policy count [3] - Yangtuo Technology Inc. operates a trading and service platform for home care and nutrition products, holding a 10.1% market share in the low-tier market [4] - Xiamen Ruiwei Information Technology Co., Ltd. specializes in image intelligent analysis products and solutions, leveraging machine learning and computer vision technologies [5] - Zijin Gold International Limited is a leading global gold mining company, ranking ninth in gold reserves and eleventh in production as of 2024 [6] - EVE Energy Co., Ltd. is a leading lithium battery platform company, ranking first in China for consumer cylindrical battery shipments and second globally for energy storage battery shipments [7] - Zhejiang Yifei Intelligent Technology Co., Ltd. is a leading industrial robotics company in China, focusing on the light industry [8] - ChipMight Semiconductor Technology (Hangzhou) Co., Ltd. is a leading power semiconductor company, ranking second in the global OLED display PMIC market [9] - Beijing Tongrentang Medical Investment Co., Ltd. is the largest non-public Chinese medicine hospital group by outpatient and inpatient visits [11] - Shandong Linglong Tire Co., Ltd. is the largest OE tire manufacturer in China and the third largest globally [12] - Magnesium Holdings Limited is an innovative automotive technology company focused on AI-driven integrated domain control solutions [13] Group 2: Public Offerings and New Listings - Seven companies initiated their public offerings, including Anjii Foods, which had a subscription rate of 44.2 times for its public offering [14][15] - Other companies like Lens Technology and Fortior also initiated their public offerings with significant interest from cornerstone investors [16][19] - Five new stocks were listed, including Yunzhisheng, which saw a closing price increase of 44.59% on its first day [20][21][22][23] Group 3: Market Insights - The Hong Kong Stock Exchange raised over HKD 107 billion in the first half of 2025, with a 20% increase in the Hang Seng Index [24] - The biopharmaceutical sector has seen a resurgence, with 10 companies successfully listing in the first half of 2025, compared to only 12 for the entire previous year [25][26] - The total fundraising amount for the biopharmaceutical sector reached HKD 15.6 billion in the first half of 2025, indicating strong market interest [26][27]

将投中网设为"星标⭐"，第一时间收获最新推送 速览投资风口，掌握资本律动。 作者丨簪竹 业投资基金共同投资。 此外，瑞桥鼎科集团宣布完成A轮融资，融资金额超过十亿元人民币。本轮 融资由康桥资本领投，北京市医药健康产业投资基金、北商资本跟投。 据投中网不完全统计，投融资详情如下（统计周期03月22日—03月28日）： 新消费 洛梵狄完成近1亿元融资 3月25日消息，智能短途出行核心零部件供应商洛梵狄智能科技（简称：洛梵狄）完成近1亿元B轮 融资，投资方有广州产投、迪策投资（湖南省钢铁集团下属投资平台）和达晨财智。 禧点茶韵完成3000万元A轮融资 来源丨投中网 大家好，我是长风。今天给大家带来上周资本市场的专业投研信息。 上周焦点回顾： 低空经济赛道，两家低空企业有钱了。 3月27日，时的科技宣布完成B+轮战略融资，本轮融资由上 海大零号湾创投和紫峰资本联合投资。同一天，翊飞航空科技也宣布完成亿元级别融资，本轮融资由 普华资本领投。 硬科技赛道，启明连投两家机器人。 3月26日消息，具身智能初创公司它石智航（TARS）宣布完成 天使轮1.2亿美元融资。本轮融资由蓝驰创投、启明创投共同领投，线性资本、恒旭资本、洪 ...